Opko Health OPK
NASDAQ OPK
$1.74 +0.04 (+2.66%)
As of: Sep 22, 2026 · 10:05 AM EDT

Opko Health (OPK) Operating Income (2010 - 2026)

Opko Health's (OPK) quarterly Operating Income came in at -$7.0 million in Q2 2026, up 88.38% on a YoY basis from -$3.7 million in Q2 2025, and up 86.33% quarter-over-quarter from -$51.0 million in Q1 2026.

Analysis

Opko Health (OPK) Operating Income (2010 - 2026) Analysis & Trends

Opko Health (OPK) has reported Operating Income for 17 consecutive years, with -$7.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Operating Income rose 88.38% year-over-year to -$7.0 million; the trailing twelve-month figure through Jun 2026 stood at -$48.2 million (up 87.28% YoY), and the FY2025 full-year result was -$117.4 million, up 22.79% from the prior year.
  • Operating Income grew to -$7.0 million in Q2 2026 per OPK's latest filing, from -$51.0 million in the prior quarter.
  • Across five years, Operating Income topped out at $48.1 million in Q3 2025 and bottomed at -$133.1 million in Q2 2024.
  • Historically, Operating Income has averaged -$51.9 million across 5 years, with a median of -$60.0 million in 2025.
  • The sharpest annual moves came in 2023 and 2024: Operating Income soared 165.42% in 2023, then plunged 1995.27% in 2024.
  • Over 5 years, Operating Income stood at -$55.3 million in 2022, then retreated by 24.93% to -$69.0 million in 2023, then sank by 72.24% to -$118.9 million in 2024, then surged by 67.78% to -$38.3 million in 2025, then jumped by 81.8% to -$7.0 million in 2026.
  • According to Business Quant data, Operating Income over the past three periods registered -$7.0 million, -$51.0 million, and -$38.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 7.14 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 6.43 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 4.75 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 4.27 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 360.00 Mn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 1.22 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -505.13 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 325.05 Mn
10 Opko Health 1.25 Bn 945.61 Mn 80.02 Mn -6.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.97 Mn
Mar 31, 2026 -51.02 Mn
Dec 31, 2025 -38.32 Mn
Sep 30, 2025 48.06 Mn
Jun 30, 2025 -59.98 Mn
Mar 31, 2025 -67.17 Mn
Sep 30, 2024 -118.93 Mn
Jun 30, 2024 -133.14 Mn
Mar 31, 2024 -71.47 Mn
Dec 31, 2023 -69.05 Mn
Sep 30, 2023 -64.41 Mn
Jun 30, 2023 7.03 Mn
Mar 31, 2023 -30.59 Mn
Dec 31, 2022 -55.27 Mn
Sep 30, 2022 -87.82 Mn
Jun 30, 2022 -10.74 Mn
Mar 31, 2022 -72.42 Mn
Dec 31, 2021 -63.08 Mn
Sep 30, 2021 37.83 Mn
Jun 30, 2021 5.57 Mn
API Access

Opko Health Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=OPK&period=max&api_key=YOUR_API_KEY